Please enable JavaScript to continue using this application.

Compare $ABSI vs $STOK | Chartloom

Compare

$ABSI vs $STOK

Absci Corp · Stoke Therapeutics Inc

ABSI

Absci Corp

STOK

Stoke Therapeutics Inc

Compare $ABSI vs $STOK

Comparing Absci Corp and Stoke Therapeutics Inc

ABSIAbsci Corp

STOKStoke Therapeutics Inc

ABSIAbsci Corp

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

486.99x

Rev growth (TTM)

-62.3%

YTD performance

181.4%

52W performance

143.1%

FCF yield

-6.4%

STOKStoke Therapeutics Inc

Market cap

$1.54B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

47.27x

Rev growth (TTM)

-86.2%

YTD performance

-19.9%

52W performance

-18.9%

FCF yield

-11.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABSI

STOK

Detailed metrics comparison

ABSI

Absci Corp

STOK

Stoke Therapeutics Inc

Market Cap

ABSI$1.72B

STOK$1.54B

Enterprise Value

ABSI$1.61B

STOK$1.43B

Price

ABSI$10.16

STOK$24.74

P/E Ratio

ABSIN/A

STOKN/A

P/S Ratio

ABSI1,098.99x

STOK55.85x

EV/Sales

ABSI1,029.98x

STOK51.86x

EV/EBITDA

ABSI0.00x

STOK53.69x

P/B Ratio

ABSI7.72x

STOK4.78x

P/FCF Ratio

ABSIN/A

STOKN/A

EV/FCF

ABSI-14.73x

STOK-7.92x

PEG Ratio

ABSIN/A

STOKN/A

Forward P/E (NTM)

ABSIN/A

STOKN/A

Forward P/S (NTM)

ABSI486.99x

STOK47.27x

Revenue (TTM)

ABSI$2M

STOK$28M

Revenue Growth (YoY)

ABSI-62.3%

STOK-86.2%

Forward Rev Growth

ABSI359.4%

STOK62.9%

Gross Margin (TTM)

ABSI0.0%

STOK0.0%

Operating Margin (TTM)

ABSI0.0%

STOK0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

STOK-803.4%

Net Margin (TTM)

ABSI-7756.4%

STOK-753.6%

FCF Margin (TTM)

ABSI-6994.2%

STOK-654.9%

Net Income (TTM)

ABSI$-121M

STOK$-208M

FCF (TTM)

ABSI$-109M

STOK$-181M

EPS (TTM)

ABSI-$0.77

STOK-$3.15

ROE (TTM)

ABSI-5921.0%

STOK-5936.0%

ROA (TTM)

ABSI-5231.0%

STOK-5146.0%

ROIC (TTM)

ABSI-5901.0%

STOK-5936.0%

Cash

ABSI$108M

STOK$110M

Debt

ABSI$150K

STOK$0

Net Cash/Debt

ABSI$108M

STOK$110M

Current Ratio (TTM)

ABSI10.63x

STOK7.69x

Quick Ratio (TTM)

ABSI10.26x

STOK7.34x

Debt/Equity (TTM)

ABSI0.00x

STOK0.00x

Debt/Assets (TTM)

ABSI0.0%

STOK0.0%

Interest Coverage (TTM)

ABSIN/A

STOKN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

STOK0.00x

Beta

ABSI2.17

STOK1.36

52W Performance

ABSI143.1%

STOK-18.9%

YTD Performance

ABSI181.4%

STOK-19.9%

% from 52W High

ABSI-15.7%

STOK-38.5%

% from 52W Low

ABSI353.6%

STOK21.8%

Asset Turnover (TTM)

ABSI0.01x

STOK0.07x

FCF Yield (TTM)

ABSI-6.4%

STOK-11.7%

Earnings Yield (TTM)

ABSI-7.1%

STOK-13.5%

Dividend Yield (TTM)

ABSIN/A

STOKN/A

Rule of 40

ABSI-7,056.5

STOK-741.1

EV/GP/RG

ABSIN/A

STOKN/A

Ticker research

View ABSI research View STOK research

Metric	ABSI Absci Corp	STOK Stoke Therapeutics Inc
Market & Valuation
Market Cap	$1.72B	$1.54B
Enterprise Value	$1.61B	$1.43B
Price	$10.16	$24.74
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	55.85x
EV/Sales	1,029.98x	51.86x
EV/EBITDA	0.00x	53.69x
P/B Ratio	7.72x	4.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.73x	-7.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	486.99x	47.27x
Revenue & Growth
Revenue (TTM)	$2M	$28M
Revenue Growth (YoY)	-62.3%	-86.2%
Forward Rev Growth	359.4%	62.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	-803.4%
Net Margin (TTM)	-7756.4%	-753.6%
FCF Margin (TTM)	-6994.2%	-654.9%
Net Income (TTM)	$-121M	$-208M
FCF (TTM)	$-109M	$-181M
EPS (TTM)	-$0.77	-$3.15
ROE (TTM)	-5921.0%	-5936.0%
ROA (TTM)	-5231.0%	-5146.0%
ROIC (TTM)	-5901.0%	-5936.0%
Financial Health
Cash	$108M	$110M
Debt	$150K	$0
Net Cash/Debt	$108M	$110M
Current Ratio (TTM)	10.63x	7.69x
Quick Ratio (TTM)	10.26x	7.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	1.36
52W Performance	143.1%	-18.9%
YTD Performance	181.4%	-19.9%
% from 52W High	-15.7%	-38.5%
% from 52W Low	353.6%	21.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.07x
FCF Yield (TTM)	-6.4%	-11.7%
Earnings Yield (TTM)	-7.1%	-13.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-741.1
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View STOK research

Valuation

P/S Ratio

STOK

55.85x

ABSI

1,098.99x

EV/FCF

ABSI

-14.73x

STOK

-7.92x

Growth & revenue

Revenue Growth TTM

ABSI

-62.3%

STOK

-86.2%

Forward Revenue Growth

ABSI

359.4%

STOK

62.9%

Profitability & performance

Gross Margin

ABSI

0.0%

STOK

0.0%

ROE

ABSI

-5921.0%

STOK

-5936.0%

FCF Yield %

ABSI

-6.4%

STOK

-11.7%

52-Week Performance

ABSI

143.1%

STOK

-18.9%

Detailed metrics comparison

ABSI

Absci Corp

STOK

Stoke Therapeutics Inc

Market Cap

ABSI$1.72B

STOK$1.54B

Enterprise Value

ABSI$1.61B

STOK$1.43B

Price

ABSI$10.16

STOK$24.74

P/E Ratio

ABSIN/A

STOKN/A

P/S Ratio

ABSI1,098.99x

STOK55.85x

EV/Sales

ABSI1,029.98x

STOK51.86x

EV/EBITDA

ABSI0.00x

STOK53.69x

P/B Ratio

ABSI7.72x

STOK4.78x

P/FCF Ratio

ABSIN/A

STOKN/A

EV/FCF

ABSI-14.73x

STOK-7.92x

PEG Ratio

ABSIN/A

STOKN/A

Forward P/E (NTM)

ABSIN/A

STOKN/A

Forward P/S (NTM)

ABSI486.99x

STOK47.27x

Revenue (TTM)

ABSI$2M

STOK$28M

Revenue Growth (YoY)

ABSI-62.3%

STOK-86.2%

Forward Rev Growth

ABSI359.4%

STOK62.9%

Gross Margin (TTM)

ABSI0.0%

STOK0.0%

Operating Margin (TTM)

ABSI0.0%

STOK0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

STOK-803.4%

Net Margin (TTM)

ABSI-7756.4%

STOK-753.6%

FCF Margin (TTM)

ABSI-6994.2%

STOK-654.9%

Net Income (TTM)

ABSI$-121M

STOK$-208M

FCF (TTM)

ABSI$-109M

STOK$-181M

EPS (TTM)

ABSI-$0.77

STOK-$3.15

ROE (TTM)

ABSI-5921.0%

STOK-5936.0%

ROA (TTM)

ABSI-5231.0%

STOK-5146.0%

ROIC (TTM)

ABSI-5901.0%

STOK-5936.0%

Cash

ABSI$108M

STOK$110M

Debt

ABSI$150K

STOK$0

Net Cash/Debt

ABSI$108M

STOK$110M

Current Ratio (TTM)

ABSI10.63x

STOK7.69x

Quick Ratio (TTM)

ABSI10.26x

STOK7.34x

Debt/Equity (TTM)

ABSI0.00x

STOK0.00x

Debt/Assets (TTM)

ABSI0.0%

STOK0.0%

Interest Coverage (TTM)

ABSIN/A

STOKN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

STOK0.00x

Beta

ABSI2.17

STOK1.36

52W Performance

ABSI143.1%

STOK-18.9%

YTD Performance

ABSI181.4%

STOK-19.9%

% from 52W High

ABSI-15.7%

STOK-38.5%

% from 52W Low

ABSI353.6%

STOK21.8%

Asset Turnover (TTM)

ABSI0.01x

STOK0.07x

FCF Yield (TTM)

ABSI-6.4%

STOK-11.7%

Earnings Yield (TTM)

ABSI-7.1%

STOK-13.5%

Dividend Yield (TTM)

ABSIN/A

STOKN/A

Rule of 40

ABSI-7,056.5

STOK-741.1

EV/GP/RG

ABSIN/A

STOKN/A

Ticker research

View ABSI research View STOK research

Metric	ABSI Absci Corp	STOK Stoke Therapeutics Inc
Market & Valuation
Market Cap	$1.72B	$1.54B
Enterprise Value	$1.61B	$1.43B
Price	$10.16	$24.74
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	55.85x
EV/Sales	1,029.98x	51.86x
EV/EBITDA	0.00x	53.69x
P/B Ratio	7.72x	4.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.73x	-7.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	486.99x	47.27x
Revenue & Growth
Revenue (TTM)	$2M	$28M
Revenue Growth (YoY)	-62.3%	-86.2%
Forward Rev Growth	359.4%	62.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	-803.4%
Net Margin (TTM)	-7756.4%	-753.6%
FCF Margin (TTM)	-6994.2%	-654.9%
Net Income (TTM)	$-121M	$-208M
FCF (TTM)	$-109M	$-181M
EPS (TTM)	-$0.77	-$3.15
ROE (TTM)	-5921.0%	-5936.0%
ROA (TTM)	-5231.0%	-5146.0%
ROIC (TTM)	-5901.0%	-5936.0%
Financial Health
Cash	$108M	$110M
Debt	$150K	$0
Net Cash/Debt	$108M	$110M
Current Ratio (TTM)	10.63x	7.69x
Quick Ratio (TTM)	10.26x	7.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	1.36
52W Performance	143.1%	-18.9%
YTD Performance	181.4%	-19.9%
% from 52W High	-15.7%	-38.5%
% from 52W Low	353.6%	21.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.07x
FCF Yield (TTM)	-6.4%	-11.7%
Earnings Yield (TTM)	-7.1%	-13.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-741.1
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View STOK research